Targeting SALL4 protein with druglike molecules could halt tumor growth, say research
 

Harvard Stem Cell Institute researchers have identified in the most aggressive forms of cancer a gene known to regulate embryonic stem cell self-renewal, beginning a creative search for a drug that can block its activity.

More...